GV, AbbVie Ventures and NS Investment have contributed to a series B round for the oncology drug developer, which has now raised a total of $103m.
Month: April 2020
HLB helps insert more funding into Immunomic
The HLB-led group owns nearly half of vaccine product developer Immunomic Therapeutics following a $61.3m commitment this year.
SwanBio swivels to $52m in series A
Partners Innovation Fund joined Syncona to provide $20m for the neurological disease drug developer’s series A round, which is sized at up to $77m.
Gojek goes for $130m Moka acquisition
SoftBank, Bank Mandiri and the corporate-backed EV Growth have exited digital payment technology provider Moka, which had raised $28m.
FreeWire gets $25m transmission
BP Ventures led a series B equity and debt round for the charger provider that also featured another corporate investor, ABB Technology Ventures.
HG Ventures traverses Equispheres investment
The high-performance metal powder developer secured $21.1m in a round led by The Heritage Group’s investment subsidiary, which provided $7m.
TapClicks takes AdStage in acquisition deal
Marketing analytics software provider Adstage had raised more than $15m from backers including Verizon, Digital Garage, HubSpot, Guidewire and Eloqua.
Leuven Instruments loops in series B financing
Red Star Macalline was among the participants in a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.
Tridge tracks $11m for series B
Forest Partners and Activant Capital have invested $11m in the SoftBank-backed agriculture trading hub.
FoRx picks up $10m in seed round
M Ventures and Novartis Venture Fund co-led a round for the oncology drug startup that also featured fellow corporate venturing unit Pfizer Ventures.
H1 Insights pinpoints series A funding
Novartis DRX was among the investors in a $12.9m for the medical personnel database operator that lifted its overall funding close to $20m.
Stepping back to the past to find the future
AmFam has made it’s first impact investment in Biobot Analytics, a platform that can trace health indicators that provide insights into drug use and the presence of viruses, environmental contaminants and nutrition.
CVC in the Time of Coronavirus: Nicolas Sauvage, TDK Ventures
TDK’s corporate venturing unit is lining up more deals to go with its investment in Genetesis this week, having been formed early last year with one eye on an economic downturn.
Slack helps guide $30m to Guru
Guru has closed a $30m series C round backed by returning investor Slack, bringing the sales advice software developer’s total funding to $68m.